Last edition
News about "mild dementia"
Eisai, Biogen Secure China Approval for Once-Weekly Leqembi Subcutaneous Autoinjector
China approves Leqembi’s once-weekly subcutaneous autoinjector, offering patients with early Alzheimer’s disease a more convenient at-home treatment option.
Mild Dementia | 04/09/2026 | By News Bureau
China Adds Leqembi to Innovative Drug Insurance List
BioArctic’s partner Eisai said Leqembi has been added to China’s new Commercial Insurance Innovative Drug List, a move by the NHSA that broadens access to the Alzheimer’s therapy for patients in the early stages of the disease.
Mild Dementia | 09/12/2025 | By Akanki | 393
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy